Jan 01,2020

System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015

Accuracy of 18 current-generation blood glucose monitoring systems (BGMS) available in Europe was evaluated applying criteria adapted from EN ISO 15197:2015 with one reagent system lot. BGMS were selected based on market research data.

CLINICAL STUDY

#bgm

View Analyst & Ambassador Comments
Go to original news
Jan 01,2020

Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease

The data suggest that CGM metrics may provide clinicians and researchers especially valuable information for evaluating risk of diabetes complications

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 02,2020

ABBOTT HOSTS CONFERENCE CALL FOR FOURTH-QUARTER EARNINGS

Abbott (NYSE: ABT) will announce its fourth-quarter 2019 financial results on Wednesday, Jan. 22, 2020, before the market opens. The announcement will be followed by a live webcast of the earnings conference call at 8:30 a.m.

View Analyst & Ambassador Comments
Go to original news
Jan 03,2020

BD to Present at the 38th Annual J.P. Morgan Healthcare Conference

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 at 6:00 p.m. ET, followed by a question and answer session at 6:30 p.m. ET.

View Analyst & Ambassador Comments
Go to original news
Jan 06,2020

Half-year report on the liquidity contract entered into with ODDO Corporate Finance

Under the liquidity contract entrusted by Voluntis to Oddo Corporate Finance, on December 31, 2019, the following resources appeared in the liquidity account: Number of shares: 27,043 shares & Balance in cash: 64,990, 80 euros

View Analyst & Ambassador Comments
Go to original news
Jan 06,2020

Insulet to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full year of 2019 on February 25, 2020 after the close of the financial markets.

View Analyst & Ambassador Comments
Go to original news
Jan 08,2020

Microfabrication of bioimpedance sensors

Utilizing carbon nanotube technology, Tula in partnership with Brigham Young University has been able to miniaturize bioimpedence sensors.

COLLABORATION PARTNERSHIP

#product & service

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 08,2020

Jana Care launches Jana Diabetes brand of chronic diabetes care innovations

Jana Care, a designer and manufacturer of point-of-care and home blood testing technology announced the launch of a new brand of products, called Jana Diabetes, under the broader Jana Care label.

PRODUCT

#mobile app

#bgm

View Analyst & Ambassador Comments
Go to original news
Jan 08,2020

Diabetologist Dr. Christopher Jones joins Tula’s team as the Chief Medical Officer

A practicing physician, Dr. Jones is the Medical Director for Diabetes Care at Intermountain Healthcare. In addition he is the Communications Director for Diabetes in Primary Care at the American Diabetes Association.

View Analyst & Ambassador Comments
Go to original news
Jan 09,2020

Tandem Diabetes Care Appoints New Executive Vice President of Strategy and Corporate Development

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Elizabeth Gasser as its new Executive Vice President, Strategy and Corporate Development.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES